ID   HOTHC
AC   CVCL_8708
DR   CLO; CLO_0050950
DR   BioSample; SAMN03472267
DR   cancercelllines; CVCL_8708
DR   DepMap; ACH-002041
DR   RCB; RCB0662
DR   Wikidata; Q54890185
RX   PubMed=10457904;
RX   PubMed=17022149;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=10457904); 24-28 hours (PubMed=17022149).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): RCB=RCB0662
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
RX   PubMed=10457904;
RA   Ishiwata I., Sudo T., Kiguchi K., Ishikawa H.;
RT   "Tumor angiogenesis factors produced by cancer cells.";
RL   Hum. Cell 12:37-46(1999).
//
RX   PubMed=17022149; DOI=10.1111/j.1749-0774.2005.tb00007.x;
RA   Ishiwata I., Ono I., Kiguchi K., Ishiwata C., Soma M., Ishikawa H.;
RT   "Establishment and characterization of a human thyroid carcinoma cell
RT   line (HOTHC) producing colony stimulating factor.";
RL   Hum. Cell 18:163-169(2005).
//